Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Regoli

Showing results (111-120 of 419) with videos related to

Pageof 42
Sort By:
Regulatory Peptides|July 2, 1993
Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesisR Couture, S Boucher, P Picard, et al.
Regulatory Peptides|July 2, 1993
Characterization of the cardiovascular and behavioral effects of centrally administered neuropeptide K in the conscious ratA Prat, P Picard, D Regoli, et al.
General Pharmacology|January 1, 1991
Effect of bradykinin antagonists, NG-monomethyl-L-arginine and L-NG-nitro arginine on phospholipase A2 induced oedema in rat pawG Cirino, C Cicala, L Sorrentino, et al.
Canadian Journal of Physiology and Pharmacology|February 1, 1989
Prostacyclin release induced by neurokinins in cultured human endothelial cellsF Marceau, B Tremblay, R Couture, et al.
European Journal of Pharmacology|September 1, 1989
Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptidesP Devillier, G Drapeau, M Renoux, et al.
British Journal of Pharmacology|October 1, 1976
Factors regulating the time-course of the relaxation of rabbit aorta strips after contraction by angiotensin II [proceedings]D Regoli, J Saint-Louis, W K Park
British Journal of Pharmacology|January 10, 1998
Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious ratE Cellier, L Barbot, D Regoli, et al.
Immunopharmacology|December 22, 1999
Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657)F Gobeil, M Montagne, N Inamura, et al.
European Journal of Pharmacology|September 5, 1980
Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car)E Escher, G Guillemette, O Leukart, et al.
Life Sciences|January 1, 1997
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric arteryG Calò, A Rizzi, L Traina, et al.
Pageof 42

Showing results (111-120 of 419) with videos related to

Sort By:
Pageof 42
Regulatory Peptides|July 2, 1993
Receptor characterization of the spinal action of neurokinins on nociception: a three receptor hypothesisR Couture, S Boucher, P Picard, et al.
Regulatory Peptides|July 2, 1993
Characterization of the cardiovascular and behavioral effects of centrally administered neuropeptide K in the conscious ratA Prat, P Picard, D Regoli, et al.
General Pharmacology|January 1, 1991
Effect of bradykinin antagonists, NG-monomethyl-L-arginine and L-NG-nitro arginine on phospholipase A2 induced oedema in rat pawG Cirino, C Cicala, L Sorrentino, et al.
Canadian Journal of Physiology and Pharmacology|February 1, 1989
Prostacyclin release induced by neurokinins in cultured human endothelial cellsF Marceau, B Tremblay, R Couture, et al.
European Journal of Pharmacology|September 1, 1989
Role of the N-terminal arginine in the histamine-releasing activity of substance P, bradykinin and related peptidesP Devillier, G Drapeau, M Renoux, et al.
British Journal of Pharmacology|October 1, 1976
Factors regulating the time-course of the relaxation of rabbit aorta strips after contraction by angiotensin II [proceedings]D Regoli, J Saint-Louis, W K Park
British Journal of Pharmacology|January 10, 1998
Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious ratE Cellier, L Barbot, D Regoli, et al.
Immunopharmacology|December 22, 1999
Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657)F Gobeil, M Montagne, N Inamura, et al.
European Journal of Pharmacology|September 5, 1980
Pharmacological properties of two analogues of angiotensin II containing carboranylalanine (Car)E Escher, G Guillemette, O Leukart, et al.
Life Sciences|January 1, 1997
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric arteryG Calò, A Rizzi, L Traina, et al.
Pageof 42